Search research articles
Contact Us
Filters
Showing results (191-200 of 217) with videos related to
Page
of 22
Sort By:
Cancer Discovery
|
November 20, 2025
Spatial multiomic analyses reveal carcinogenic pathways in end-stage renal disease
Jun Takahashi, Yosuke Tanaka, Yusuke Sato, et al.
Scientific Reports
|
July 10, 2021
Natal origin and age-specific egress of Pacific bluefin tuna from coastal nurseries revealed with geochemical markers
Jay R Rooker, R J David Wells, Barbara A Block, et al.
Cell Reports
|
August 25, 2021
A histone modifier, ASXL1, interacts with NONO and is involved in paraspeckle formation in hematopoietic cells
Keita Yamamoto, Susumu Goyama, Shuhei Asada, et al.
Microbiology Spectrum
|
April 25, 2025
Molecular epidemiology and clinical features of <i>Klebsiella variicola</i> bloodstream infection compared with infection with other <i>Klebsiella pneumoniae</i> species complex strains
Tatsuya Ohno, Sohei Harada, Hiroki Saito, et al.
Nature Communications
|
July 18, 2018
Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis
Shuhei Asada, Susumu Goyama, Daichi Inoue, et al.
Development (Cambridge, England)
|
September 26, 2014
Single-cell analyses of regulatory network perturbations using enhancer-targeting TALEs suggest novel roles for PU.1 during haematopoietic specification
Adam C Wilkinson, Viviane K S Kawata, Judith Schütte, et al.
Cell Reports
|
December 19, 2019
Discrimination of Dormant and Active Hematopoietic Stem Cells by G<sub>0</sub> Marker Reveals Dormancy Regulation by Cytoplasmic Calcium
Tsuyoshi Fukushima, Yosuke Tanaka, Fiona K Hamey, et al.
Plos One
|
December 2, 2015
Discovery of a Good Responder Subtype of Esophageal Squamous Cell Carcinoma with Cytotoxic T-Lymphocyte Signatures Activated by Chemoradiotherapy
Yosuke Tanaka, Kazuhiko Aoyagi, Keiko Minashi, et al.
Cell Reports
|
September 15, 2023
Mitotic perturbation is a key mechanism of action of decitabine in myeloid tumor treatment
Tomohiro Yabushita, Takumi Chinen, Atsuya Nishiyama, et al.
Nature Communications
|
January 13, 2022
Eliminating chronic myeloid leukemia stem cells by IRAK1/4 inhibitors
Yosuke Tanaka, Reina Takeda, Tsuyoshi Fukushima, et al.
Page
of 22
Search research articles
Search
Showing results (191-200 of 217) with videos related to
Sort By:
Page
of 22
Cancer Discovery
|
November 20, 2025
Spatial multiomic analyses reveal carcinogenic pathways in end-stage renal disease
Jun Takahashi, Yosuke Tanaka, Yusuke Sato, et al.
Scientific Reports
|
July 10, 2021
Natal origin and age-specific egress of Pacific bluefin tuna from coastal nurseries revealed with geochemical markers
Jay R Rooker, R J David Wells, Barbara A Block, et al.
Cell Reports
|
August 25, 2021
A histone modifier, ASXL1, interacts with NONO and is involved in paraspeckle formation in hematopoietic cells
Keita Yamamoto, Susumu Goyama, Shuhei Asada, et al.
Microbiology Spectrum
|
April 25, 2025
Molecular epidemiology and clinical features of <i>Klebsiella variicola</i> bloodstream infection compared with infection with other <i>Klebsiella pneumoniae</i> species complex strains
Tatsuya Ohno, Sohei Harada, Hiroki Saito, et al.
Nature Communications
|
July 18, 2018
Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis
Shuhei Asada, Susumu Goyama, Daichi Inoue, et al.
Development (Cambridge, England)
|
September 26, 2014
Single-cell analyses of regulatory network perturbations using enhancer-targeting TALEs suggest novel roles for PU.1 during haematopoietic specification
Adam C Wilkinson, Viviane K S Kawata, Judith Schütte, et al.
Cell Reports
|
December 19, 2019
Discrimination of Dormant and Active Hematopoietic Stem Cells by G<sub>0</sub> Marker Reveals Dormancy Regulation by Cytoplasmic Calcium
Tsuyoshi Fukushima, Yosuke Tanaka, Fiona K Hamey, et al.
Plos One
|
December 2, 2015
Discovery of a Good Responder Subtype of Esophageal Squamous Cell Carcinoma with Cytotoxic T-Lymphocyte Signatures Activated by Chemoradiotherapy
Yosuke Tanaka, Kazuhiko Aoyagi, Keiko Minashi, et al.
Cell Reports
|
September 15, 2023
Mitotic perturbation is a key mechanism of action of decitabine in myeloid tumor treatment
Tomohiro Yabushita, Takumi Chinen, Atsuya Nishiyama, et al.
Nature Communications
|
January 13, 2022
Eliminating chronic myeloid leukemia stem cells by IRAK1/4 inhibitors
Yosuke Tanaka, Reina Takeda, Tsuyoshi Fukushima, et al.
Page
of 22